Call For Advanced Technology

There have been significant technological advancements in autonomous infrastructure within the transportation and mining industry with heavy duty equipment, trucks, buses, recreational vehicles and others used for goods movement. We are interested in how companies and organizations with technical readiness can assist the forestry industry in advancing their current operations and utilizing existing Intelligent Transportation Systems (ITS).

Background

Across Ontario, the forestry industry is faced with timber hauling logistics challenges. Currently, the hauling capacity cannot match the pace of harvesting equipment and mill consumption. Wood is often left roadside longer than it should be in many forest management units, waiting for transportation before being brought to the mills. Ultimately, wood left roadside leads to issues at various processing facilities, including lack of inventory in yards and increased costs.

Nextfor, in partnership with The Nawiinginokiima Forest Management Corporation (NFMC) are interested in identifying parties who can bring innovative, technical solutions to address the identified timber hauling logistics challenges.

Goals and Outcomes

The purpose of this EOI is to gain an understanding of the available state of technology and organizational capacity to undertake future full-scale field trial(s) and pilot projects to demonstrate innovative technology and solutions to the identified challenge, specifically:

• Explore available technologies and providers who can address the logistics issues facing wood transport processes,
• Find technology (hardware or software) in the pre-commercial or commercial stage which addresses the unique needs of the forestry sector, and;
• Identify and connect a consortium of service providers for future RFP and logistics opportunities.

The FY20 Defense Appropriations Act provides funding to the Department of Defense Combat Readiness – Medical Research Program (CRRP) to support military-relevant advanced technology and therapeutic research related to forward-deployable solutions that can promptly address life-threatening injuries, medical threats, and treatments for Service members in current and future battlefield settings.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Broad Agency Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC).

The FY20 Congressional language for the CRRP considered research that would enable the Warfighter to better respond to serious injury, as well as solutions to mitigate the long-term effects of battlefield trauma.  The FY20 CRRP Broad Agency Announcement and General Submission Instructions for the following award mechanism are posted on the Grants.gov website. 

The FY20 CRRP is soliciting research applications addressing at least one of the Focus Areas described below.  The Focus Areas broadly describe current needs to ensure readiness for delivering front-line care in combat situations and for delivering medical damage control capability, assets, and lifesaving interventions to address the emerging needs of the Warfighter and Service medics during prolonged and en route care in austere and combat environments, including the acute and early management of combat-related trauma at the point of injury. 

Applications submitted to the FY20 CRRP must address at least one of the following Focus Areas:

• Multiple-use scalable wound-care solutions that can address prevention of bleeding and infection, delivery of therapeutics, and promotion of healing spanning acute through chronic care
• Repair and/or restoration of combat-related genitourinary organ and tissue damage
• Solutions for assessment of mild traumatic brain injury in deployed and far-forward settings to include portable devices
• Research and development of freeze-dried plasma and platelets to address hemorrhage and resuscitation
• Solutions to enhance Warfighter readiness in battlefield and austere environments including the prevention and treatment of:

○        Gastrointestinal illness such as Enterotoxigenic Escherichia coli diarrheal disease and inflammatory bowel disease

○        Sleep disorders

○        Myalgic encephalomyelitis/chronic fatigue syndrome

○        Infectious diseases

• Enhanced delivery and utilization of telemedicine platforms

https://cdmrp.army.mil/funding/crrp

Rapid Development and Translational Research Award – Preproposal due September 10, 2020

Independent investigators at all academic levels (or equivalent)

Proposals/applications must be submitted through an extramural organization

Intramural investigators may be named as a collaborator on a proposal/application submitted through an extramural organization

• Supports new ideas that represent military-relevant advanced technology and therapeutic research related to forward-deployable solutions that can promptly address life-threatening injuries, medical threats and treatments for Warfighters in current and future battlefield setting.
• Supports research that will accelerate the movement of promising ideas into clinical applications, including healthcare products, technologies, and/or practice guidelines. This mechanism is not intended to support fundamental basic research.
• Primary emphasis will be placed on the potential impact of the proposed work.
• Preclinical research supported by substantial preliminary or published data that validates clinical translation is appropriate for this mechanism.
• Clinical trials are not allowed.
• Must address at least one of the FY20 CRRP Focus Areas.
• Maximum funding of $2,000,000 for direct costs (plus indirect costs)
• Maximum period of performance is 2 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Broad Agency Announcement and General Submission Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for the award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when the Broad Agency Announcement is released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the CRRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBRap.org

The Ontario SPOR SUPPORT Unit (OSSU) is inviting proposals from qualified groups for additional knowledge translation and implementation funding to empower patient oriented research projects to achieve broader impacts on health, health policy and health system for Ontario. The EMPOWER Awards (Engaging Multi-stakeholders for Patient Oriented research Wider Effects & Reach) provide a structure (integrating the Ontario SPOR SUPPORT Unit and its Research Centres) and funding (up to $25,000) to allow existing patient-oriented research projects that require additional support to have impacts. Applications are invited from research teams that have completed or are completing patient-oriented research studies that have demonstrable patient partnership. EMPOWER Awardees will be expected to also build patient partnership into their EMPOWER Award. EMPOWER Awards are for a maximum duration of six months.

In the EMPOWER Awards III, OSSU is soliciting proposals that relate patient-partnered and citizen/public engaged research that has the capacity to deliver impacts related to COVID-19 challenges in Ontario. The original patient partnered research need not be on the subject of COVID-19 itself, but the application and impact of the work should be relevant to the needs of stakeholders in the province (from patients, to healthcare practitioners, to health policy and the health system).

Click here for more detailed information and related documents.

Partnership Engage Grants are expected to respond to the objectives of the Insight program and the Connection program. However, Partnership Engage Grants cannot respond exclusively to the objectives of the Connection program.

These grants provide short-term and timely support for partnered research activities that will inform decision-making at a single partner organization from the public, private or not-for-profit sector. The small-scale, stakeholder-driven partnerships supported through Partnership Engage Grants are meant to respond to immediate needs and time constraints facing organizations in non-academic sectors. In addressing an organization-specific need, challenge and/or opportunity, these partnerships let non-academic organizations and postsecondary researchers access each other’s unique knowledge, expertise and capabilities on topics of mutual interest.

SSHRC welcomes applications involving Indigenous research, as well as those involving research-creation.

For tools and resources to assist in the planning and implementation of your partnership, see SSHRC’s Partnerships Tool-Kit.